The impact of pulmonary diseases on the fate of inhaled medicines—A review
YB Wang, AB Watts, JI Peters, RO Williams III - International journal of …, 2014 - Elsevier
The portfolio of compounds approved for inhalation therapy has expanded rapidly for
treatment of lung diseases. To assess the efficacy and safety of inhaled medicines, a better …
treatment of lung diseases. To assess the efficacy and safety of inhaled medicines, a better …
Bioavailability and pharmacokinetics of inhaled drugs
AL Adjei, Y Qiu, PK Gupta - Inhalation Aerosols, 2006 - taylorfrancis.com
The evolution of lung drug-delivery technology has undergone significant advances over the
last few decades, so that today it is one of the most effective and rapid modalities for treating …
last few decades, so that today it is one of the most effective and rapid modalities for treating …
Aerosol technology to mimic dry powder inhalation in vitro using pulmonary cell models
AM Ledo, S Thibodeaux, L Duong, E Altinoglu… - European Journal of …, 2023 - Elsevier
Inhaled therapy confers key advantages for the treatment of topical pulmonary diseases and
offers potential for systemic delivery of medicines. Dry powder inhalers (DPIs) are generally …
offers potential for systemic delivery of medicines. Dry powder inhalers (DPIs) are generally …
Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compound
BM Lue, FS Nielsen, T Magnussen, HM Schou… - European Journal of …, 2008 - Elsevier
The usefulness of selected biorelevant dissolution media (BDM) to predict in vivo drug
absorption was studied. Dissolution profiles of solid formulations of a poorly soluble model …
absorption was studied. Dissolution profiles of solid formulations of a poorly soluble model …
Comparison and analysis of theoretical models for diffusion-controlled dissolution
Y Wang, B Abrahamsson, L Lindfors… - Molecular …, 2012 - ACS Publications
Dissolution models require, at their core, an accurate diffusion model. The accuracy of the
model for diffusion-dominated dissolution is particularly important with the trend toward …
model for diffusion-dominated dissolution is particularly important with the trend toward …
In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals
Delivery of therapeutic agents via the pulmonary route has gained significant attention over
the past few decades because this route of administration offers multiple advantages over …
the past few decades because this route of administration offers multiple advantages over …
Utilization of gastrointestinal simulator, an in vivo predictive dissolution methodology, coupled with computational approach to forecast oral absorption of dipyridamole
K Matsui, Y Tsume, S Takeuchi, A Searls… - Molecular …, 2017 - ACS Publications
Weakly basic drugs exhibit a pH-dependent dissolution profile in the gastrointestinal (GI)
tract, which makes it difficult to predict their oral absorption profile. The aim of this study was …
tract, which makes it difficult to predict their oral absorption profile. The aim of this study was …
Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration
E Nicolaides, M Symillides, JB Dressman… - Pharmaceutical …, 2001 - Springer
Purpose. To quantitatively compare in vitro dissolution data in biorelevant and compendial
media, to investigate whether in vitro differences are reflected in the simulated plasma …
media, to investigate whether in vitro differences are reflected in the simulated plasma …
The development of models for the evaluation of pulmonary drug disposition
Introduction: The process of drug disposition in the lung after pulmonary delivery is complex
involving absorptive and non-absorptive mechanisms. The lung has also been suggested to …
involving absorptive and non-absorptive mechanisms. The lung has also been suggested to …